Scleroligation for Eradication of Gastroesophageal Varices.
NCT ID: NCT02646202
Last Updated: 2017-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
90 participants
INTERVENTIONAL
2015-01-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sclerotherapy group
thirty patients treated by sclerotherapy for OV using ethanolamine oleate 5%.
Sclerotherapy
Injection of varices
Endoscopic band ligation group
thirty patients treated by endoscopic banding using the Euro-Ligator system.
Band ligation
endoscopic banding of varices
Sclero-ligation (SL) group
thirty patients treated by intra variceal endoscopic sclerotherapy combined with band ligation.
Scleroligation
intra variceal endoscopic sclerotherapy combined with band ligation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sclerotherapy
Injection of varices
Band ligation
endoscopic banding of varices
Scleroligation
intra variceal endoscopic sclerotherapy combined with band ligation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Any terminal illness, such as heart failure, uremia, or chronic pulmonary diseases.
* Other potential causes of GIT bleeding.
* Patients with previous endoscopic or surgical intervention for varices were also excluded.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Consultant liver and GIT diseases- Tanta university hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ferial El-kalla, Professor
Role: PRINCIPAL_INVESTIGATOR
Head of endoscopy unit - Tropical medicine department- Tanta
Mohamed Elhendawy, Consultant
Role: PRINCIPAL_INVESTIGATOR
liver diseases dept.- Tanta university hospital
Loai Mansour, Consultant
Role: STUDY_DIRECTOR
liver diseases dept.-Tanta university hospital
Abdelrahman kobtan, Consultant
Role: STUDY_CHAIR
liver diseases dept.-Tanta university hospital
Rehab Badawy, Consultant
Role: STUDY_CHAIR
liver diseases dept.-Tanta university hospital
Hanan Elbasat, Professor
Role: STUDY_CHAIR
liver diseases dept.-Tanta university hospital
Sherief Abd-Elsalam, Consultant
Role: STUDY_CHAIR
Liver diseases and gastroenterology dept.-Tanta university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tropical medicine dept.-Tanta university hospital
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sherief Abd-Elsalam
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Mansour L, El-Kalla F, El-Bassat H, Abd-Elsalam S, El-Bedewy M, Kobtan A, Badawi R, Elhendawy M. Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices. Gastrointest Endosc. 2017 Aug;86(2):307-315. doi: 10.1016/j.gie.2016.12.026. Epub 2017 Jan 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Scleroligation
Identifier Type: -
Identifier Source: org_study_id